Agreement brings IFA test kits and instruments to the US
Aesku. Click to read more...
Stay updated with breaking news from Torsten Matthias. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aesku. Click to read more...
MODAG Initiates First-in-Patient Phase 1b Trial for Anle138b in Parkinson's Disease MODAG, a German biotechnology company focused on the development of disease-modifying small molecule therapeutics for neurodegenerative diseases, today announced the clinical trial initiation of a first-in-patient Phase 1b study for anle138b in patients with mild to moderate Parkinson's Disease (PD). Anle138b is a disease-modifying treatment option for synucleinopathies, such as Multiple System Atrophy (MSA) and PD. The short-term Phase 1b study with PD patients will be conducted by Quotient Sciences in Nottin...